ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,261 | -13.0% | 60,514 | 0.0% | 0.01% | -20.0% |
Q2 2023 | $1,449 | +27.2% | 60,514 | 0.0% | 0.01% | +25.0% |
Q1 2023 | $1,139 | +12.8% | 60,514 | -4.7% | 0.01% | 0.0% |
Q4 2022 | $1,010 | -99.9% | 63,470 | -5.5% | 0.01% | 0.0% |
Q3 2022 | $1,099,000 | +16.2% | 67,147 | 0.0% | 0.01% | +14.3% |
Q2 2022 | $946,000 | -41.8% | 67,147 | 0.0% | 0.01% | -30.0% |
Q1 2022 | $1,626,000 | +45.6% | 67,147 | +41.5% | 0.01% | +66.7% |
Q4 2021 | $1,117,000 | -25.9% | 47,457 | -47.7% | 0.01% | -25.0% |
Q3 2021 | $1,507,000 | -61.0% | 90,757 | -42.7% | 0.01% | -66.7% |
Q2 2021 | $3,862,000 | +310.0% | 158,357 | +333.6% | 0.02% | +300.0% |
Q1 2021 | $942,000 | -0.8% | 36,522 | +86.3% | 0.01% | -25.0% |
Q2 2020 | $950,000 | – | 19,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |